{
    "2019-12-27": [
        [
            {
                "time": "",
                "original_text": "万泰生物被问询不正当竞争、商业贿赂等四大问题 询问",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "不正当竞争",
                        "商业贿赂",
                        "问询"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-01",
                "original_text": "万泰生物IPO过会 旗下子公司HPV疫苗有望2020年1月获批",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "IPO",
                        "HPV疫苗",
                        "获批"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物首发上会通过 旗下HPV疫苗进入最后审批阶段",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "首发上会",
                        "HPV疫苗",
                        "审批"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "12月",
                "original_text": "12月第四批IPO获全员通过 并购重组惨遇“双杀”",
                "features": {
                    "keywords": [
                        "IPO",
                        "并购重组",
                        "双杀"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}